What sector does Pasithea Therapeutics Corp. (KTTA) operate in?
Pasithea Therapeutics Corp. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Pasithea Therapeutics Corp. (KTTA) current stock price?
As of the latest data, Pasithea Therapeutics Corp. stock price is $0.69, with a previous close of $0.67. Pasithea Therapeutics Corp. gained $0.01 in the last trading session, representing a 2.17% increase.
What is Pasithea Therapeutics Corp. (KTTA) current market capitalization?
Pasithea Therapeutics Corp. market cap is approximately 17.18 million.
What is Pasithea Therapeutics Corp. (KTTA) Earnings Per Share (EPS)?
The trailing EPS is -$2.91, and the forward EPS is -$2.10.
What is Pasithea Therapeutics Corp. (KTTA) EBITDA?
Pasithea Therapeutics Corp. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -10.10 million.
Does Pasithea Therapeutics Corp. (KTTA) pay dividends?
No. Pasithea Therapeutics Corp. does not pay a dividend.
What is Pasithea Therapeutics Corp. (KTTA) beta (volatility) score?
Pasithea Therapeutics Corp. has a beta of 0.253, indicating lower volatility than the overall market.